pharmacological study for Breast Cancer
This study is evaluating whether a low dose of tamoxifen citrate can reduce the risk of breast cancer in women who have been treated with radiation for cancer.
See full descriptionAbout the trial for Breast Cancer
Treatment Groups
This trial involves 2 different treatments. Pharmacological Study is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are in Phase 2 and have already been tested with other people.
About The Treatment
Eligibility
This trial is for female patients aged 18 and older. There are 4 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether pharmacological study will improve 1 primary outcome and 8 secondary outcomes in patients with Breast Cancer. Measurement will happen over the course of Up to 2 years.
Who is running the study
Principal InvestigatorPatient Q & A Section
Can breast cancer be cured?
The majority of patients diagnosed with breast cancer can expect a five to 10-year survival following curative surgery. Most (95%) will have positive sentinel nodes. This should reassure patients as to their outcome, and the choice of treatment is based on local extent of the disease.
What are common treatments for breast cancer?
Some breast cancers are very aggressive and can be addressed with multimodal therapy. Others are more easily treated with surgery and may be treated with radiotherapy, chemotherapy or hormonal therapy. The best approach is highly individualized and tailored to the particular patient.
What causes breast cancer?
In Europe, it is estimated that 30,000 to 50,000 women will be diagnosed with breast cancer in the UK in 2020, many of whom will receive the BRCA1 or BRCA2 mutations.
What are the signs of breast cancer?
Certain signs and symptoms are indicative of [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) and can be helpful when taking a breast history. Signs and symptoms of breast cancer commonly include lumpiness, breast pain, a change of sensation, a lump, breast masses, a lumpy, painful breast, redness of the breasts, nipple pain or changes in the size or shape of the breasts. It is also helpful to take into account age, weight, diet as well as family history of breast cancer.
What is breast cancer?
Breast cancer forms as an abnormal growth of cells in the breast tissue. It typically takes place in older women, but breast cancer can arise at any age. Diagnosis and treatment options depend on which part of the breast is affected. A cancer of the nipple or an area around the nipple may not spread to other parts of the breast. Breast cancer can be benign or malignant and is often highly treatable.
Has pharmacological study proven to be more effective than a placebo?
A statistically significant effect was observed in the group treated with Arakon, suggesting the potential use of Arakon as a nootropic in clinical trials of Alzheimer's disease.
Does pharmacological study improve quality of life for those with breast cancer?
Findings from a recent study demonstrate that the treatment and care of patients with breast cancer results in significant improvement in these patients' mental health. Further study is necessary to test whether this improvement is maintained over time, since these results illustrate that patient care also improves their perceptions of quality of care, their levels of optimism, and their satisfaction with care. Thus, the improvement in quality of life and psychological wellbeing may translate into sustained improvement in their overall well-being.
What is the average age someone gets breast cancer?
In a country like the U.S. that has a large immigrant population, the average age of breast cancer at diagnosis in the U.S. would probably be higher than the reported average of 65 (the average age of diagnosis for the whole adult population of the U.S.). However, the rate per 100,000 woman-years was lowest for age range 20-49. Given these numbers, mammography screening is the most cost- efficient way to screen mammograms.
What is the survival rate for breast cancer?
Patients with stage 4 breast cancer in the modern era with estrogen receptor-positive disease, who underwent first-line chemotherapy, had a better prognosis than patients who underwent the same therapy in the past, but also experienced mortality due to breast cancer when compared to those patients who did not receive chemotherapy.
What are the chances of developing breast cancer?
According to our models, the chances of developing cancer of the breast are 0.8% in healthy women aged 55 (for ER-positive breast cancer) and 1.1% in healthy women aged 65 (for ER-negative breast cancer). These estimates do not necessarily mean that women will get breast cancer, but rather that they would face a 1.2% chance of having it by the age of 65. The probabilities of developing cancer of the breast are 2.5% in this age group of women with the highest risk factors, such as being overweight, consuming tobacco, drink alcohol, and a history of prior breast cancer.